Top Stories
Filed under:
Can the US cut drug prices without sacrificing new cures?
The big unanswered question at the heart of Democrats’ health care agenda.
Biden’s incoherent immigration policy
President Biden proposed humane immigration reforms but continued harsh, Trump-era enforcement policies at the border.
When removing a statue actually is antidemocratic
A university’s orders to remove a Tiananmen Square monument show how deep Beijing’s Hong Kong crackdown goes.
Startups are betting on a psychedelic gold rush
A startup called Field Trip is opening clinics to administer ketamine treatments. Others may follow.
Why Merck’s Covid-19 pill molnupiravir could be so important
The pharma giant said its new antiviral drug cut hospitalizations in half for at-risk Covid-19 patients.
Bryan Stevenson on tracing the legacy of American enslavement to mass incarceration
The lawyer discusses expanding a museum on enslaved people and why working to end racism isn’t enough.
Why so many people undercharge for their work
Setting a rate can be a minefield for folks navigating an industry alone.
The problem with America’s semi-rich
America’s upper-middle class works more, optimizes their kids, and is miserable.
Sign up for the newsletter VoxCare
Dylan Scott guides you through the fallout of the Covid-19 pandemic and the health care policies that matter most.